Advaxis Stock Price - ADXS

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Pre-Market
Last Trade
Last $ 0.35 ▼ -0.00 (-0.31%)
Company Name Stock Ticker Symbol Market Type
Advaxis Inc ADXS NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 0.3511 0.00 0.00 0.00 0.3511 09:13:20
Bid Price Ask Price Spread Spread % News
0.347 0.35 0.003 0.86% - -
Stock Trades Traded Volume Average Volume 52 Week Range
42 62,342 10,267,567 0.181 - 10.80
Last Trade Time Type Quantity Stock Price Currency
09:13:20 formt 303 $ 0.35 USD

Advaxis Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 8.68M 24.71M $ -66.52M -19.74 - 20.30M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 23.60%

more financials information »

Advaxis News

Date Time Source News Article
10/15/201907:14InvestorsHub NewsWireCLS Holdings (CLSH) Record Q1 Results - $1.15 Price Target..
10/04/201916:32Edgar (US Regulatory)Current Report Filing (8-k)
9/13/201916:31Edgar (US Regulatory)Current Report Filing (8-k)
9/09/201916:31Edgar (US Regulatory)Current Report Filing (8-k)
9/09/201916:02Edgar (US Regulatory)Quarterly Report (10-q)
9/06/201916:31Edgar (US Regulatory)Current Report Filing (8-k)
8/22/201916:15Edgar (US Regulatory)Current Report Filing (8-k)

Latest ADXS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADXS Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.290.370.2750.33206M0.061121.07%
1 Month0.270.60.2020.335912M0.081130.04%
3 Months0.580.60.2020.33496M-0.2289-39.47%
6 Months3.34.210.2020.44083M-2.9489-89.36%
1 Year0.64110.80.1810.66642M-0.2899-45.23%
3 Years8.8310.880.1812.25971M-8.4789-96.02%
5 Years2.8730.130.1816.41041M-2.5189-87.77%

Advaxis Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.
Your Recent History
NASDAQ
ADXS
Advaxis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191022 13:30:58